| 淡江大學 |
Oral presentation on |
BoEs: Attachable Haptics Bits On Gaming Controller For Designing Interactive Gameplay
|
Han, P. H.;Chen, Y. S.;Yang, K. T.;Chuan, W. S.;Chang, Y. T.;Yang, T. M.;Lin, J. Y.;Lee, K. C.;Hsieh, C. E.;Lee, L. C.;Chou, C. H.;Hung, Y. P. |
| 國立成功大學 |
2023 |
Anticancer polypyrrole-polyethylenimine drug-free nanozyme for precise B-cell lymphoma therapy
|
Nguyen, T.T.;Chuang, E.-Y.;Chen, Y.-P.;Tseng, P.-C.;Jhan, M.-K.;Lai, C.-Y.;Wang, Y.-T.;Hung, Y.-P.;Changou, Changou C.A.;Lee, C.-M.;Chen, Chen C.-L.;Lin, C.-F. |
| 國立成功大學 |
2023 |
Association of Single Nucleotide Polymorphisms in Nucleotide-Binding Domain Leucine-Rich Repeat Protein 1 with Clostridioides difficile Colonization or Infection
|
Tsai, B.-Y.;Tsai, P.-J.;Lee, C.-C.;Chiu, Chiu C.-W.;Lai, Y.-H.;Lee, J.-C.;Ko, W.-C.;Hung, Y.-P. |
| 臺大學術典藏 |
2022-08-19T00:20:34Z |
An Open-Label, Single-Arm, Two-Stage, Multicenter, Phase II Study to Evaluate the Efficacy of TLC388 and Genomic Analysis for Poorly Differentiated Neuroendocrine Carcinomas
|
Chen M.-H.; Chou W.-C.; Hsiao C.-F.; Jiang S.S.; Tsai H.-J.; Liu Y.-C.; CHIUN HSU; Shan Y.-S.; Hung Y.-P.; Hsich C.-H.; Chiu C.-H.; Liu T.-C.; Cho S.-F.; Liu T.-W.; Chao Y. |
| 臺大學術典藏 |
2022-08-19T00:20:30Z |
Potential of circulating immune cells as biomarkers of nivolumab treatment efficacy for advanced hepatocellular carcinoma
|
Hung Y.-P.; Shao Y.-Y.; Lee J.-M.; CHIUN HSU; Hsu C.-H.; Yang M.-H.; Chao Y. |
| 臺大學術典藏 |
2022-08-19T00:20:28Z |
The unique characteristic in peripheral immune cells in patients with advanced hepatocellular carcinoma
|
Hung Y.-P.; CHIUN HSU; Lee J.-M.; Chao Y.; Shao Y.-Y.; Hsu C.-H.; Yang M.-H. |
| 臺大學術典藏 |
2022-08-12T06:28:16Z |
Validation of a computer-based bronchoscopy simulator developed in Taiwan
|
Chen J.-S.; Hsu H.-H.; Lai I.-R.; Tai H.-C.; Lai H.-S.; Lee Y.-C.; Shaw J.-S.; Hung Y.-P.; Lee P.-H.; KING-JEN CHANG; Cheng H.-J.; Shao J.-M.; Lai F.; Shau Y.-W.; Hsiung C.-W. |
| 臺大學術典藏 |
2022-08-12T06:28:02Z |
Multimedia feedback for improving breathing habit
|
Yu M.-C.; Ko J.-C.; Lin C.-Y.; Chang C.-H.; Yang Y.-H.; Lin S.-C.; Chen J.-S.; KING-JEN CHANG; Kuo S.-W.; Hsu S.-C.; Hung Y.-P. |
| 臺大學術典藏 |
2022-08-12T06:27:51Z |
i-m-Space: Interactive multimedia-enhanced space for rehabilitation of breast cancer patients
|
Ko J.-C.; Chen W.-H.; Yu M.-C.; Lin H.-H.; Lin J.-Y.; Wu S.-W.; Chung Y.-Y.; Hu I.-L.; Peng W.-T.; Lin S.-Y.; Chang C.H.; Chou P.-H.; KING-JEN CHANG; Chang M.-L.; Chen S.-H.; Chen J.-S.; Lee M.-S.; Chen M.Y.; Hung Y.-P. |
| 臺大學術典藏 |
2022-08-12T06:27:50Z |
I-m-Breath: The effect of multimedia biofeedback on learning abdominal breath
|
Yu M.-C.; Chen J.-S.; KING-JEN CHANG; Hsu S.-C.; Lee M.-S.; Hung Y.-P. |
| 臺大學術典藏 |
2022-08-12T06:27:38Z |
Opportunities for persuasive technology to motivate heavy computer users for stretching exercise
|
Chen Y.-X.; Chiang S.-S.; Chih S.-Y.; Liao W.-C.; Lin S.-Y.; Yang S.-H.; Cheng S.-W.; Lin S.-S.; Lin Y.-S.; Lee M.-S.; Tsauo J.-Y.; Jen C.-M.; Shih C.-S.; KING-JEN CHANG; Hung Y.-P. |
| 臺大學術典藏 |
2022-06-10T06:10:55Z |
A Multicenter Phase II Study of Second-Line Axitinib for Patients with Advanced Hepatocellular Carcinoma Failing First-Line Sorafenib Monotherapy
|
ZHONG-ZHE LIN; Chen B.-B.; Hung Y.-P.; Huang P.-H.; Shen Y.-C.; Shao Y.-Y.; Hsu C.-H.; Cheng A.-L.; Lee R.-C.; Chao Y.; Hsu C. |
| 臺大學術典藏 |
2022-05-13T08:04:13Z |
Chlorhexidine bathing to prevent central line- associated bloodstream infections in hematology units: A prospective, controlled cohort study
|
Tien K.-L.; Sheng W.-H.; Shieh S.-C.; Hung Y.-P.; Tien H.-F.; Chen Y.-H.; Chien L.-J.; JANN-TAY WANG; Fang C.-T.; Chen Y.-C. |
| 臺大學術典藏 |
2022-03-10T02:31:37Z |
Genes involved in angiogenesis and mTOR pathways are frequently mutated in Asian patients with pancreatic neuroendocrine tumors
|
Chou W.-C.; PO-HAN LIN; Yeh Y.-C.; Shyr Y.-M.; Fang W.-L.; Wang S.-E.; Liu C.-Y.; Chang P.M.-H.; Chen M.-H.; Hung Y.-P.; Li C.-P.; Chao Y.; Chen M.-H. |
| 臺大學術典藏 |
2022-02-07T03:29:06Z |
Potential of circulating immune cells as biomarkers of nivolumab treatment efficacy for advanced hepatocellular carcinoma
|
Hung Y.-P.; Shao Y.-Y.; Lee J.-M.; Hsu C.; CHIH-HUNG HSU; Yang M.-H.; Chao Y. |
| 臺大學術典藏 |
2022-02-07T03:29:05Z |
The unique characteristic in peripheral immune cells in patients with advanced hepatocellular carcinoma
|
Hung Y.-P.; Shao Y.-Y.; Hsu C.; CHIH-HUNG HSU; Lee J.-M.; Yang M.-H.; Chao Y. |
| 臺大學術典藏 |
2022-01-24T06:05:36Z |
Potential of circulating immune cells as biomarkers of nivolumab treatment efficacy for advanced hepatocellular carcinoma
|
Hung Y.-P.; Shao Y.-Y.; Lee J.-M.; CHIUN HSU; Hsieh C.-H.; Yang M.-H.; Chao Y. |
| 臺大學術典藏 |
2022-01-24T06:05:35Z |
The unique characteristic in peripheral immune cells in patients with advanced hepatocellular carcinoma
|
Hung Y.-P.; Shao Y.-Y.; CHIUN HSU; Hsieh C.-H.; Lee J.-M.; Yang M.-H.; Chao Y. |
| 國立成功大學 |
2022 |
Peroxisome proliferator-activated receptor-γ as the gatekeeper of tight junction in Clostridioides difficile infection
|
Lai, Y.-H.;Wu, T.-C.;Tsai, B.-Y.;Hung, Y.-P.;Lin, H.-J.;Tsai, Y.-S.;Ko, W.-C.;Tsai, P.-J. |
| 國立成功大學 |
2022 |
Impaired Chromatin Remodeling Predicts Better Survival to Modified Gemcitabine and S-1 plus Nivolumab in Advanced Biliary Tract Cancer: A Phase II T1219 Study
|
Chiang, N.-J.;Tan, K.T.;Bai, L.-Y.;Hsiao, C.-F.;Huang, C.-Y.;Hung, Y.-P.;Huang, C.-J.;Chen, S.-C.;Shan, Y.-S.;Chao, Y.;Huang, Y.-H.;Lee, I.-C.;Lee, P.-C.;Su, Y.-Y.;Chen, S.-J.;Yeh, C.-N.;Chen, L.-T.;Chen, M.-H. |
| 國立成功大學 |
2022 |
COVID-19-associated candidiasis and the emerging concern of Candida auris infections
|
Tsai, C.-S.;Lee, S.S.-J.;Chen, W.-C.;Tseng, C.-H.;Lee, N.-Y.;Chen, P.-L.;Li, M.-C.;Syue, L.-S.;Lo, C.-L.;Ko, W.-C.;Hung, Y.-P. |
| 臺大學術典藏 |
2021-09-14T02:45:52Z |
Multicenter evaluation of two chemiluminescence and three lateral flow immunoassays for the diagnosis of COVID-19 and assessment of antibody dynamic responses to SARS-CoV-2 in Taiwan
|
Chen S.-Y.; Lee Y.-L.; Lin Y.-C.; Lee N.-Y.; Liao C.-H.; Hung Y.-P.; Lu M.-C.; JHONG-LIN WU; Tseng W.-P.; Lin C.-H.; Chung M.-Y.; Kang C.-M.; Lee Y.-F.; Lee T.-F.; Cheng C.-Y.; Chen C.-P.; Huang C.-H.; Liu C.-E.; Cheng S.-H.; Ko W.-C.; Hsueh P.-R.; Chen S.-C. |
| 臺大學術典藏 |
2021-09-02T00:04:56Z |
Quantitative spectroscopic comparison of the optical properties of mouse cochlea microstructures using optical coherence tomography at 1.06 μm and 1.3 μm wavelengths
|
Tsa T.-Y;Chen T.-H;Chen H.-C;Chueh C.-B;Huang Y.-P;Hung Y.-P;Tsai M.-T;Baumann B;Wang C.-H;Lee H.-C.; Tsa T.-Y; Chen T.-H; Chen H.-C; Chueh C.-B; Huang Y.-P; Hung Y.-P; Tsai M.-T; Baumann B; Wang C.-H; Lee H.-C.; HSIANG-CHIEH LEE |
| 臺大學術典藏 |
2021-08-31T06:29:21Z |
Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
|
Lu L.-C.; Hsu C.; Shao Y.-Y.; Chao Y.; Yen C.-J.; Shih I.-L.; Hung Y.-P.; Chang C.-J.; Shen Y.-C.; Guo J.-C.; Liu T.-H.; Hsu C.-H.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-08-31T06:29:15Z |
A Multicenter Phase II Study of Second-Line Axitinib for Patients with Advanced Hepatocellular Carcinoma Failing First-Line Sorafenib Monotherapy
|
Lin Z.-Z.; Chen B.-B.; Hung Y.-P.; Huang P.-H.; Shen Y.-C.; Shao Y.-Y.; Hsu C.-H.; ANN-LII CHENG; Lee R.-C.; Chao Y.; Hsu C. |
| 臺大學術典藏 |
2021-08-18T07:39:05Z |
Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
|
Lu L.-C.; Hsu C.; Shao Y.-Y.; Chao Y.; Yen C.-J.; Shih I.-L.; Hung Y.-P.; Chang C.-J.; Shen Y.-C.; JHE-CYUAN GUO; Liu T.-H.; Hsu C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2021-08-11T03:46:34Z |
A Multicenter Phase II Study of Second-Line Axitinib for Patients with Advanced Hepatocellular Carcinoma Failing First-Line Sorafenib Monotherapy
|
ZHONG-ZHE LIN; Chen B.-B.; Hung Y.-P.; Huang P.-H.; Shen Y.-C.; Shao Y.-Y.; Hsu C.-H.; Cheng A.-L.; Lee R.-C.; Chao Y.; Hsu C. |
| 臺大學術典藏 |
2021-08-03T07:10:54Z |
Potential of circulating immune cells as biomarkers of nivolumab treatment efficacy for advanced hepatocellular carcinoma
|
Hung Y.-P.; YU-YUN SHAO; Lee J.-M.; Hsu C.; Hsu C.-H.; Yang M.-H.; Chao Y. |
| 臺大學術典藏 |
2021-08-03T07:10:52Z |
The unique characteristic in peripheral immune cells in patients with advanced hepatocellular carcinoma
|
Hung Y.-P.; YU-YUN SHAO; Hsu C.; Hsu C.-H.; Lee J.-M.; Yang M.-H.; Chao Y. |
| 臺大學術典藏 |
2021-06-03T06:15:37Z |
Genes involved in angiogenesis and mTOR pathways are frequently mutated in Asian patients with pancreatic neuroendocrine tumors
|
Chou W.-C.; PO-HAN LIN; Yeh Y.-C.; Shyr Y.-M.; Fang W.-L.; Wang S.-E.; Liu C.-Y.; Chang P.M.-H.; Chen M.-H.; Hung Y.-P.; Li C.-P.; Chao Y.; Chen M.-H. |
| 臺大學術典藏 |
2021-05-31T02:56:55Z |
SaFePlay: A lightweight portable sensing system to estimate knee adduction moment
|
Wei S.-Y.;Lo Y.-P.;Lin C.-Y.;Lin T.-Y.;Chou Y.-Y.;Huang J.-T.;Rong-Sen Yang;Hung Y.-P.; Wei S.-Y.; Lo Y.-P.; Lin C.-Y.; Lin T.-Y.; Chou Y.-Y.; Huang J.-T.; RONG-SEN YANG; Hung Y.-P. |
| 臺大學術典藏 |
2021-05-24T03:42:06Z |
Validation of a computer-based bronchoscopy simulator developed in Taiwan
|
Chen J.-S.; HSAO-HSUN HSU; Lai I.-R.; Tai H.-C.; Lai H.-S.; Lee Y.-C.; Shaw J.-S.; Hung Y.-P.; Lee P.-H.; Chang K.-J.; Cheng H.-J.; Shao J.-M.; Lai F.; Shau Y.-W.; Hsiung C.-W. |
| 臺大學術典藏 |
2021-05-07T08:04:40Z |
Multicenter evaluation of two chemiluminescence and three lateral flow immunoassays for the diagnosis of COVID-19 and assessment of antibody dynamic responses to SARS-CoV-2 in Taiwan
|
Chen S.-Y.;Lee Y.-L.;Lin Y.-C.;Lee N.-Y.;Liao C.-H.;Hung Y.-P.;Lu M.-C.;Wu J.-L.;Tseng W.-P.;Chien-Hao Lin;Chung M.-Y.;Kang C.-M.;Lee Y.-F.;Lee T.-F.;Cheng C.-Y.;Chen C.-P.;Huang C.-H.;Liu C.-E.;Cheng S.-H.;Ko W.-C.;Hsueh P.-R.;Chen S.-C.; Chen S.-Y.; Lee Y.-L.; Lin Y.-C.; Lee N.-Y.; Liao C.-H.; Hung Y.-P.; Lu M.-C.; Wu J.-L.; Tseng W.-P.; CHIEN-HAO LIN; Chung M.-Y.; Kang C.-M.; Lee Y.-F.; Lee T.-F.; Cheng C.-Y.; Chen C.-P.; Huang C.-H.; Liu C.-E.; Cheng S.-H.; Ko W.-C.; Hsueh P.-R.; Chen S.-C. |
| 臺大學術典藏 |
2021-05-07T06:54:30Z |
Multicenter evaluation of two chemiluminescence and three lateral flow immunoassays for the diagnosis of COVID-19 and assessment of antibody dynamic responses to SARS-CoV-2 in Taiwan
|
Chen S.-Y.;Lee Y.-L.;Lin Y.-C.;Lee N.-Y.;Liao C.-H.;Hung Y.-P.;Lu M.-C.;Wu J.-L.;Wen-Pin Tseng;Lin C.-H.;Chung M.-Y.;Kang C.-M.;Lee Y.-F.;Lee T.-F.;Cheng C.-Y.;Chen C.-P.;Huang C.-H.;Liu C.-E.;Cheng S.-H.;Ko W.-C.;Hsueh P.-R.;Chen S.-C.; Chen S.-Y.; Lee Y.-L.; Lin Y.-C.; Lee N.-Y.; Liao C.-H.; Hung Y.-P.; Lu M.-C.; Wu J.-L.; WEN-PIN TSENG; Lin C.-H.; Chung M.-Y.; Kang C.-M.; Lee Y.-F.; Lee T.-F.; Cheng C.-Y.; Chen C.-P.; Huang C.-H.; Liu C.-E.; Cheng S.-H.; Ko W.-C.; Hsueh P.-R.; Chen S.-C. |
| 臺大學術典藏 |
2021-05-06T02:18:17Z |
Development of a long-wavelength swept-source optical coherence tomography system for high-content ex vivo tissue imaging
|
Chueh, C.-B.; Tsai, T.-Y.; Huang, Y.-P.; Chen, T.-H.; Tsai, Y.-N.; Wang, C.-Y.; Chang, T.-C.; Hung, Y.-P.; Lee, H.-C.; YI-PING HUNG; Hsiang-Chieh? Lee |
| 臺大學術典藏 |
2021-05-06T02:18:17Z |
Differentiation of the microvasculature with different blood flow speed based on variable interscan time analysis in OCT angiography skin imaging
|
Tsai, T.-Y.; Huang, Y.-P.; Chen, T.-H.; Chueh, C.-B.; Peng, H.-Y.; Wu, M.-S.; Wu, Y.-C.; Hung, Y.-P.; Tsai, M.-T.; Lee, H.-C.; YI-PING HUNG; Hsiang-Chieh? Lee |
| 臺大學術典藏 |
2021-05-06T02:18:17Z |
Effects of parent-based social media and moderate exercise on the adherence and pulmonary functions among asthmatic children
|
Lin, H.-H.;Hung, Y.-P.;Weng, S.-H.;Lee, P.-Y.;Sun, W.-Z.Yi-Ping Hung;Wei-Zen Sun; Lin, H.-H.; Hung, Y.-P.; Weng, S.-H.; Lee, P.-Y.; Sun, W.-Z.; YI-PING HUNG; WEI-ZEN SUN |
| 臺大學術典藏 |
2021-05-06T02:18:16Z |
Utilizing handheld wind feedback to expand the perception of environmental wind from stationary device
|
Hsieh, C.-E.; Chen, Y.-T.; Wang, H.-C.; Chen, Y.-S.; Han, P.-H.; Hung, Y.-P.; YI-PING HUNG |
| 臺大學術典藏 |
2021-05-06T02:18:16Z |
The Single Software Architecture Supporting Fourier Domain Optical Coherence Tomography System
|
Huang, Y.-P.; Tsai, T.-Y.; Chen, T.-H.; Chueh, C.-B.; Hung, Y.-P.; Lee, H.-C.; YI-PING HUNG; Hsiang-Chieh? Lee |
| 臺大學術典藏 |
2021-04-20T03:46:00Z |
Chlorhexidine bathing to prevent central line- associated bloodstream infections in hematology units: A prospective, controlled cohort study
|
Tien K.-L.; Sheng W.-H.; Shieh S.-C.; Hung Y.-P.; Tien H.-F.; Chen Y.-H.; Chien L.-J.; Wang J.-T.; CHI-TAI FANG; Chen Y.-C. |
| 臺大學術典藏 |
2021-03-19T01:54:19Z |
Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
|
Lu L.-C.; Hsu C.; Shao Y.-Y.; Chao Y.; Yen C.-J.; Shih I.-L.; Hung Y.-P.; Chang C.-J.; Shen Y.-C.; Guo J.-C.; TSUNG-HAO LIU; Hsu C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2021-03-15T07:44:43Z |
Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
|
Li-Chun Lu;Hsu C.;Shao Y.-Y.;Chao Y.;Yen C.-J.;Shih I.-L.;Hung Y.-P.;Chang C.-J.;Shen Y.-C.;Guo J.-C.;Liu T.-H.;Hsu C.-H.;Cheng A.-L.; LI-CHUN LU; Hsu C.; Shao Y.-Y.; Chao Y.; Yen C.-J.; Shih I.-L.; Hung Y.-P.; Chang C.-J.; Shen Y.-C.; Guo J.-C.; Liu T.-H.; Hsu C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2021-03-09T05:18:31Z |
Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
|
Lu L.-C.; Hsu C.; Shao Y.-Y.; Chao Y.; Yen C.-J.; Shih I.-L.; Hung Y.-P.; Chang C.-J.; Ying-Chun Shen; Guo J.-C.; Liu T.-H.; Hsu C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2021-03-09T05:18:29Z |
A Multicenter Phase II Study of Second-Line Axitinib for Patients with Advanced Hepatocellular Carcinoma Failing First-Line Sorafenib Monotherapy
|
Lin Z.-Z.; Chen B.-B.; Hung Y.-P.; Huang P.-H.; Ying-Chun Shen; Shao Y.-Y.; Hsu C.-H.; Cheng A.-L.; Lee R.-C.; Chao Y.; Hsu C. |
| 臺大學術典藏 |
2021-02-26T01:59:09Z |
Chlorhexidine bathing to prevent central line- associated bloodstream infections in hematology units: A prospective, controlled cohort study
|
Tien K.-L.; WANG-HUEI SHENG; Shieh S.-C.; Hung Y.-P.; Tien H.-F.; Chen Y.-H.; Chien L.-J.; Wang J.-T.; Fang C.-T.; Chen Y.-C. |
| 臺大學術典藏 |
2021-02-25T07:00:59Z |
The unique characteristic in peripheral immune cells in patients with advanced hepatocellular carcinoma
|
Hung Y.-P.;Yu-Yun Shao;Hsu C.;Hsu C.-H.;Lee J.-M.;Yang M.-H.;Chao Y.; Hung Y.-P.; YU-YUN SHAO; Hsu C.; Hsu C.-H.; Lee J.-M.; Yang M.-H.; Chao Y. |
| 臺大學術典藏 |
2021-02-25T07:00:58Z |
A Multicenter Phase II Study of Second-Line Axitinib for Patients with Advanced Hepatocellular Carcinoma Failing First-Line Sorafenib Monotherapy
|
Lin Z.-Z.;Chen B.-B.;Hung Y.-P.;Huang P.-H.;Shen Y.-C.;Yu-Yun Shao;Hsu C.-H.;Cheng A.-L.;Lee R.-C.;Chao Y.;Hsu C.; Lin Z.-Z.; Chen B.-B.; Hung Y.-P.; Huang P.-H.; Shen Y.-C.; YU-YUN SHAO; Hsu C.-H.; Cheng A.-L.; Lee R.-C.; Chao Y.; Hsu C. |
| 臺大學術典藏 |
2021-02-19T06:52:27Z |
The unique characteristic in peripheral immune cells in patients with advanced hepatocellular carcinoma
|
Hung Y.-P.;Shao Y.-Y.;Hsu C.;Chih-Hung Hsu;Lee J.-M.;Yang M.-H.;Chao Y.; Hung Y.-P.; Shao Y.-Y.; Hsu C.; CHIH-HUNG HSU; Lee J.-M.; Yang M.-H.; Chao Y. |
| 臺大學術典藏 |
2021-02-18T02:33:48Z |
Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
|
Lu L.-C.;Shao Y.-Y.;Chao Y.;Yen C.-J.;Shih I.-L.;Hung Y.-P.;Chang C.-J.;Shen Y.-C.;Guo J.-C.;Liu T.-H.;Chiun Hsu;Cheng A.-L.; Lu L.-C.; Shao Y.-Y.; Chao Y.; Yen C.-J.; Shih I.-L.; Hung Y.-P.; Chang C.-J.; Shen Y.-C.; Guo J.-C.; Liu T.-H.; Chiun Hsu; Cheng A.-L. |
| 臺大學術典藏 |
2021-02-18T02:09:12Z |
The unique characteristic in peripheral immune cells in patients with advanced hepatocellular carcinoma
|
Hung Y.-P.;Shao Y.-Y.;Chiun Hsu;Lee J.-M.;Yang M.-H.;Chao Y.; Hung Y.-P.; Shao Y.-Y.; Chiun Hsu; Lee J.-M.; Yang M.-H.; Chao Y. |
